publications | techInvention

Publication accpetance - 2023

Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial

Journal name: The Lancet Regional Health - Southeast Asia

Authors: Sanket Shah, Ranjan Kumar Nandy, Shaily S. Sethi, Bhakti Chavan, Sarang Pathak, Shanta Dutta, Sanjay Rai, Chandramani Singh, Vinod Chayal, Chintan Patel, N.Ravi Kumar, Abhishek T. Chavan, Amit Chawla, Anit Singh, Anupriya Khare Roy, Nidhi Singh, Yeong Ok Baik, Youngjin Lee, Youngran Park, Kyung Ho Jeong, Syed Ahmed

Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens

Journal name: Beyond antibiotics

Authors: Sanket Shah, Ritam Das, Bhakti Chavan, Urmi Bajpai, Sarmad Hanif, Syed Ahmed

COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries

Journal name: Vaccine

Publication house and country: Elsevier, Netherlands

Authors: Syed Ahmed, Sarang Pathak, Sanket Shah, Susmita Mukherjee, Piyali Majumder, Kafil Ahmed, Vyankatesh Pidiyar, Ganesh Kumraj, Bhawna Verma

Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward

Journal name: Human Vaccines and Immunother-apeutics

Publication house and country: Taylor and Francis, UK

Authors: Syed Ahmed, Sarang Pathak, Sanket Shah, Sarmad Hanif, Susmita Mukherjee, Piyali Majumder, Ganesh Kumraj, Jainendra Jain, Davender Bhati

Discovery of anti-CMV neutralizing antibodies from naïve scFv phage display antibody library from Indian genotype' Conferece: 2023 International Society for Vaccines - ISV Annual Congress

Date: October 22–24, 2023

Host Country: Lausanne, Switzerland.

Development of an Affordable Neisseria Meningitidis Serogroup B Vaccine for LMICs

Conference: University of Birmingham BactiVac's 4th Annual Network Meeting,

Date: October 18–19, 2023

Host Country: Birmingham, UK.

Anti-SARS-CoV-2 Antibodies Isolated From Phage Display Antibody Library Neutralizes SARS-CoV-2 Wild-Type And Different Variants of Concern

41st Annual meeting of European Society for Paediatric Infectious Diseases (ESPID)

DATE: 8^th to 12^th May 2023

Host country: Portugal

Authors: Bincy Mary, Nida Qureshi, Sanket Shah, Syed Ahmed, Kafil Ahmed, Vyankatesh Pidiyar, Ajit Chande

Anti-biofilm activity of endolysin against uropathogenic Escherichia coli

41st Annual meeting of European Society for Paediatric Infectious Diseases (ESPID)

DATE: 8^th to 12^th May 2023

Host country: Portugal

Authors: Utkarsh Gaharwar, Sakshi Dhar, Sonia Nain, Vaishali Gupta, Sarmad Hanif, Bhakti Chavan, Safia Syeda, Aasiya Choudhary, Sanket Shah, Syed Ahmed, Urmi Bajpai, Ritam Das, Deepa Sikriwal

Phage-encoded lysins: A promising approach to treat urinary tract infections caused by uropathogenic Escherichia coli

Annual Conference 2023, Microbiology Society

DATE: 17^th to 20^th April 2023

Host country: England

Authors: Utkarsh Gaharwar, Sakshi Dhar, Sonia Nain, Vaishali Gupta, Sarmad Hanif, Bhakti Chavan, Sanket Shah, Syed Ahmed, Urmi Bajpai, Ritam Das, Deepa Sikriwal

Lysins as promising antibacterial agents against Uropathogenic Escherichia coli

DATE: 18^th November 2022

Host country: India

Authors: Syed Ahmed, Sarmad Hanif, Sanket Shah, Bhakti Chavan, Urmi Bajpai, Ritam Das

Constructing Highly Diverse Antibody Library from Indian Population: An Approach Towards the Discovery of Chikungunya Virus Neutralizing Antibodies

DATE: 18^th November 2022

Host country: India

Authors: Syed Ahmed, Sanket Shah, Kafil Ahmed, Vyankatesh Pidiyar

Phage-encoded lysins as promising antibacterials against Uropathogenic Escherichia coli

BSAC Winter Conference: Infection 2022

DATE: 13^th to 14^th December 2022

Host country: England

Authors: Syed Ahmed, Sarmad Hanif, Sanket Shah, Bhakti Chavan, Urmi Bajpai, Ritam Das

Lysins as promising antibacterial therapeutics against uropathogenic Escherichia coli

ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

DATE: 4^th to 7^th October 2022

Host country: Ireland

Authors: Syed Ahmed, Sarmad Hanif, Sanket Shah, Bhakti Chavan, Urmi Bajpai, Ritam Das

Discovery of Chikungunya Virus Neutralizing Antibodies from Highly Diverse antibody library constructed from Indian population

2022 International Society of Vaccines Annual Congress

DATE: 18^th to 20^th September 2022

Host country: Canada

Authors: Syed Ahmed, Sanket Shah, Kafil Ahmed, Vyankatesh Pidiyar

Lysins as promising antibacterial agents against Uropathogenic Escherichia coli

International Union of Microbiological Societies 2022

DATE: 20^th to 22^nd July 2022

Host country: Netherlands

Authors: Syed Ahmed, Sarmad Hanif, Sanket Shah, Bhakti Chavan, Bhakti Chavan, Urmi Bajpai, Ritam Das

Lysins as promising therapeutics against Uropathogenic Escherichia coli

Australian Society for Microbiology Annual Scientific Meeting 2022

DATE: 11^th to 14^th July 2022

Host country: Australia

Authors: Syed Ahmed, Sarmad Hanif, Sanket Shah, Bhakti Chavan, Bhakti Chavan, Urmi Bajpai, Ritam Das

One Health for All: Lysins as a plausible therapy and a putative tool to address AMR

Drug Resistance Gordon Research Conference

DATE: 26^thJune to 1^th July 2022

Host country: United States of America

Authors: Syed Ahmed, Sarmad Hanif, Sanket Shah, Bhakti Chavan, Urmi Bajpai, Ritam Das

Lysins as antibacterials against Uropathogenic Escherichia coli

6^th International Symposium on Immunobiologicals

DATE: 3^rd to 5^th May 2021

Host country: Brazil

Authors: Syed Ahmed, Sarmad Hanif, Sanket Shah, Bhakti Chavan, Urmi Bajpai, Ritam Das

Evaluating the Virus Neutralizing Effect of SARS-CoV-2 Neutralizing Antibodies Developed by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology

40^th Annual meeting of European Society for Paediatric Infectious Diseases (ESPID)

DATE: 9^th to 13^th May 2022

Host country: Greece

Authors: Syed Ahmed, Sanket Shah, Safia Syeda Kafil Ahmed, Vyankatesh Pidiyar

Evaluating the Virus Neutralizing Effect of SARS-CoV-2 Neutralizing Antibodies Developed by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology

Annual Conference 2022, Microbiology Society

DATE: 4^th to 7^th April 2022

Host country: Ireland

Authors: Syed Ahmed, Sanket Shah, Safia Syeda Kafil Ahmed, Vyankatesh Pidiyar

Developing safe, effective and affordable Bi-antigen SARS-CoV-2 Vaccine candidate comprising S1 subunit and N protein expressed in Pichia pastoris for the Developing Countries

Biotherapeutics and Vaccines Development Gordon Research Conference

DATE: 27^th March to 1^st April 2022

Host country: United States of America

Authors: Syed Ahmed, Sanket Shah, Piyali Majumder, Ganesh Kumraj, Jainendra Jain, Davender Bhati

A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine consisting of S1 Subunit and N protein, expressed in Pichia pastoris: A Safe, Effective and Affordable Candidate Designed for Low- and Middle-Income Countries

Darwin 2021

DATE: 2^th to 5^th December 2021

Host country: India

Authors: Syed Ahmed, Sanket Shah, Piyali Majumder, Ganesh Kumraj, Jainendra Jain, Davender Bhati

Development of SARS-CoV-2 Neutralizing Antibodies by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology

British Society of Immunology Congress 2021

DATE: 28^th November to 1^th December 2021

Host country: Scotland

Authors: Syed Ahmed, Sanket Shah, Kafil Ahmed, Vyankatesh Pidiyar

A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine comprising S1 Subunit and N protein expressed in Pichia pastoris: A Low-cost, Safe and Effective Candidate for Low- and Middle-Income Countries.

International Conference on Biotechnology and Biological Sciences Biospectrum 2021

DATE: 18^th to 20^th November 2021

Host country: India

Authors: Syed Ahmed, Sanket Shah, Piyali Majumder, Ganesh Kumraj, Jainendra Jain, Davender Bhati

Developing safe, effective and affordable Multiantigen SARS-CoV-2 Vaccine comprising S1, S2, M and N protein expressed in Pichia pastoris for Low-and-Middle Income Countries

18^th Asia Pacific Congress of Clinical Microbiology and Infection

DATE: 11^th to 13^th November 2021

Host country: Singapore

Authors: Syed Ahmed, Sanket Shah, Ganesh Kumraj, Jainendra Jain, Davender Bhati

Construction of Highly Diverse Antibody Libraries from Indian population: An Approach for Discovery of SARS CoV 2 Neutralizing Antibodies

18^th Asia Pacific Congress of Clinical Microbiology and Infection

DATE: 11^th to 13^th November 2021

Host country: Singapore

Authors: Syed Ahmed, Sanket Shah, Kafil Ahmed, Vyankatesh Pidiyar

A Bi-Antigen Recombinant Subunit SARS-Cov-2 Vaccine Comprising S1 Subunit and N Protein Expressed In Pichia Pastoris: A Low-Cost, Safe And Effective Candidate For Low- And Middle-Income Countries

International Conference on Infections and Immunity

DATE: 8^th to 10^th October 2021

Host country: India

Authors: Syed Ahmed, Sanket Shah, Piyali Majumder, Ganesh Kumraj, Jainendra Jain, Davender Bhati

PDF

A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine comprising S1 Subunit and N protein, expressed in Pichia pastoris: A Low-cost, Safe and Effective Candidate Designed for Developing Countries

Vaccine Summit 2021

DATE: 18^th to 20^th September 2021

Host country: United States of America

Authors: Syed Ahmed, Sanket Shah, Piyali Majumder, Ganesh Kumraj, Jainendra Jain, Davender Bhati

Developing Low-cost, Safe and Effective Bi-antigen SARS-CoV-2 Vaccine comprising S1 subunit and N protein expressed in Pichia pastoris for Developing Countries

2021 International Society of Vaccines Annual Conference

DATE: 13^th to 15^th September 2021

Host country: United States of America

Authors: Syed Ahmed, Sanket Shah, Piyali Majumder, Ganesh Kumraj, Jainendra Jain, Davender Bhati

PDF

Development of SARS-CoV-2 Neutralizing Antibodies by Constructing Highly Diverse Antibody Libraries from Indian Population

2021 International Society of Vaccines Annual Conference

DATE: 13^th to 15^th September 2021

Host country: United States of America

Authors: Syed Ahmed, Sanket Shah, Kafil Ahmed, Vyankatesh Pidiyar

PDF

SARS-CoV-2 S1, S2, M & N antigens expressed in Pichia pastoris: Affordable, safe & effective vaccine for developing countries

International Symposium on Immunobiogicals

DATE: 3^rd to 5^th May 2021

Host country: Brazil

Authors: Syed Ahmed, Sanket Shah, Ganesh Kumraj, Jainendra Jain, Davender Bhati

Development of anti-SARS-CoV-2 specific scFv antibody library from convalescent plasma of COVID-19 recovered patients using phage display technology

International Symposium on Immunobiogicals

DATE: 3^th to 5^th May 2021

Host country: Brazil

Authors: Syed Ahmed, Sanket Shah, Kafil Ahmed, Vyankatesh Pidiyar

Disclaimer

Publication accpetance - 2023

Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial

Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens

Publication acceptance - 2022

COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries

Publication acceptance - 2021

Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward

Abstract acceptance - 2023

Discovery of anti-CMV neutralizing antibodies from naïve scFv phage display antibody library from Indian genotype' Conferece: 2023 International Society for Vaccines - ISV Annual Congress

Development of an Affordable Neisseria Meningitidis Serogroup B Vaccine for LMICs

Abstract acceptance for poster presentation – 2023

Anti-SARS-CoV-2 Antibodies Isolated From Phage Display Antibody Library Neutralizes SARS-CoV-2 Wild-Type And Different Variants of Concern

Anti-biofilm activity of endolysin against uropathogenic Escherichia coli

Phage-encoded lysins: A promising approach to treat urinary tract infections caused by uropathogenic Escherichia coli

Abstract acceptance for poster presentation – 2022

Lysins as promising antibacterial agents against Uropathogenic Escherichia coli

Constructing Highly Diverse Antibody Library from Indian Population: An Approach Towards the Discovery of Chikungunya Virus Neutralizing Antibodies

Phage-encoded lysins as promising antibacterials against Uropathogenic Escherichia coli

Lysins as promising antibacterial therapeutics against uropathogenic Escherichia coli

Discovery of Chikungunya Virus Neutralizing Antibodies from Highly Diverse antibody library constructed from Indian population

Lysins as promising antibacterial agents against Uropathogenic Escherichia coli

Lysins as promising therapeutics against Uropathogenic Escherichia coli

One Health for All: Lysins as a plausible therapy and a putative tool to address AMR

Lysins as antibacterials against Uropathogenic Escherichia coli

Evaluating the Virus Neutralizing Effect of SARS-CoV-2 Neutralizing Antibodies Developed by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology

Evaluating the Virus Neutralizing Effect of SARS-CoV-2 Neutralizing Antibodies Developed by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology

Developing safe, effective and affordable Bi-antigen SARS-CoV-2 Vaccine candidate comprising S1 subunit and N protein expressed in Pichia pastoris for the Developing Countries

Abstract acceptance for poster presentation – 2021

A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine consisting of S1 Subunit and N protein, expressed in Pichia pastoris: A Safe, Effective and Affordable Candidate Designed for Low- and Middle-Income Countries

Development of SARS-CoV-2 Neutralizing Antibodies by Constructing Highly Diverse Antibody Libraries from Indian Population using Phage Display Technology

A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine comprising S1 Subunit and N protein expressed in Pichia pastoris: A Low-cost, Safe and Effective Candidate for Low- and Middle-Income Countries.

Developing safe, effective and affordable Multiantigen SARS-CoV-2 Vaccine comprising S1, S2, M and N protein expressed in Pichia pastoris for Low-and-Middle Income Countries

Construction of Highly Diverse Antibody Libraries from Indian population: An Approach for Discovery of SARS CoV 2 Neutralizing Antibodies

A Bi-Antigen Recombinant Subunit SARS-Cov-2 Vaccine Comprising S1 Subunit and N Protein Expressed In Pichia Pastoris: A Low-Cost, Safe And Effective Candidate For Low- And Middle-Income Countries

A Bi-Antigen Recombinant Subunit SARS-CoV-2 Vaccine comprising S1 Subunit and N protein, expressed in Pichia pastoris: A Low-cost, Safe and Effective Candidate Designed for Developing Countries

Developing Low-cost, Safe and Effective Bi-antigen SARS-CoV-2 Vaccine comprising S1 subunit and N protein expressed in Pichia pastoris for Developing Countries

Development of SARS-CoV-2 Neutralizing Antibodies by Constructing Highly Diverse Antibody Libraries from Indian Population

SARS-CoV-2 S1, S2, M & N antigens expressed in Pichia pastoris: Affordable, safe & effective vaccine for developing countries

Development of anti-SARS-CoV-2 specific scFv antibody library from convalescent plasma of COVID-19 recovered patients using phage display technology

Our Services

Quick Links

Follow us on: